Proactive Investors - Run By Investors For Investors

Amphion Innovations reveals new report implying increased valuation for Polarean Imaging

The group develops equipment that enables existing MRI systems to achieve an improved level of imaging
MRI scanner with medic alongside
Pictured is an MRI scanner

Medical and technology investor Amphion Innovations Plc (LON:AMP) has updated on the credentials of its portfolio firm Polarean Imaging Limited, saying the float on AIM is progressing.

Polarean, which is a specialist in MRI technology, is being prepared for an AIM market float this year– after raising US$2mln in pre-IPO financing during 2016.

READ: Amphion Innovations unit DataTern says it is confident its patents are valid after US court setback

The group develops equipment that enables existing MRI systems to achieve an improved level of lung function imaging.

Significantly, it has clear guidance from the US FDA on the start of a pivotal Phase III trial on its flagship drug-device platform.

Amphion said that Northland Capital Partners, acting as Polarean's joint corporate broker, has today published a research report ahead of an investor roadshow.

READ: Amphion Innovations pinning hopes on Polarean Inc after Motif Bio success

The report anticipates a pre-IPO valuation of Polarean of around US$29 mln, compared with the valuation of circa US$22mln(on a post new money basis) implied by the pre-IPO fundraise of US$2 million in May this year.

Amphion has an interest in around 26% of the firm.

View full AMP profile View Profile

Amphion Innovations PLC Timeline

Related Articles

Big lorry
August 25 2018
"Trains, planes and automobiles" - it's the name of a classic John Hughes film but it might also be a good title for the story of Seeing Machines
Iran sanctions cartoon
September 21 2018
The group has been providing baggage screening services at Freetown International Airport in Sierra Leone for the past five years
November 16 2018
The e-learning specialist upgraded its long-term goals to run-rate revenues of £200mln and run-rate underlying earnings of at least £55mln by 2021, an increase of around 100%

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use